The influence of postmenopausal Estrogen/Progestin therapy on glucose and insulin concentrations and the risk of diabetes in postmenopausal women-the women's health initiative

被引:0
|
作者
Howard, B
Margolis, K
Allen, C
Bassford, T
Bonds, D
Burke, G
Phillips, L
Rodabough, R
Tinker, L
Torrens, J
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A142 / A142
页数:1
相关论文
共 50 条
  • [1] Effect of estrogen plus progestin on stroke in postmenopausal women - The Women's Health Initiative: A randomized trial
    Wassertheil-Smoller, S
    Hendrix, SL
    Limacher, M
    Heiss, G
    Kooperberg, C
    Baird, A
    Kotchen, T
    Curb, JD
    Black, H
    Rossouw, JE
    Aragaki, A
    Safford, M
    Stein, E
    Laowattana, S
    Mysiw, WJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (20): : 2673 - 2684
  • [2] Influence of estrogen plus progestin on breast, cancer and mammography in healthy postmenopausal women - The Women's Health Initiative Randomized trial
    Chlebowski, RT
    Hendrix, SL
    Langer, RD
    Stefanick, ML
    Gass, M
    Lane, D
    Rodabough, RJ
    Gilligan, MA
    Cyr, MG
    Thomson, CA
    Khandekar, J
    Petrovitch, H
    McTiernan, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (24): : 3243 - 3253
  • [3] Estrogen/progestin (E+P) therapy and gallbladder outcomes in postmenopausal sal women: The women's health initiative (WHI)
    Cirillo, D
    Wallace, R
    Rodabough, R
    Greenland, P
    LaCroix, A
    Limacher, M
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (11) : S99 - S99
  • [4] Estrogen plus progestin influence on mammogram density in healthy postmenopausal women in the women's health initiative randomized trial.
    McTiernan, A
    Martin, C
    Peck, JD
    Aragaki, A
    Chlebowski, R
    Pisano, E
    Wang, CY
    Brunner, R
    Johnson, KC
    Manson, JE
    Lewis, CE
    Kotchen, JM
    Hulka, B
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1905S - 1906S
  • [5] Postmenopausal hormone therapy and body composition - a substudy of the estrogen plus progestin trial of the Women's Health Initiative
    Chen, Z
    Bassford, T
    Green, SB
    Cauley, JA
    Jackson, RD
    LaCroix, AZ
    Leboff, M
    Stefanick, ML
    Margolis, KL
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 82 (03): : 651 - 656
  • [6] Breast cancer after stopping estrogen plus progestin in postmenopausal women in the women's health initiative.
    Chlebowski, R. T.
    Kuller, L.
    Anderson, G.
    Mason, J. A.
    Schenken, R.
    Rajkovic, A.
    Stefanick, M.
    Sarto, G.
    Ravdin, P.
    Prentice, R.
    CANCER RESEARCH, 2009, 69 (02) : 78S - 79S
  • [7] Influence of estrogen and progestin therapy on progression of coronary calcifications in postmenopausal women
    Becker, A
    Leber, AW
    von Ziegler, F
    Becker, C
    Knez, A
    CIRCULATION, 2005, 112 (17) : U478 - U478
  • [8] Statin Use and Risk of Diabetes Mellitus in Postmenopausal Women in the Women's Health Initiative
    Culver, Annie L.
    Ockene, Ira S.
    Balasubramanian, Raji
    Olendzki, Barbara C.
    Sepavich, Deidre M.
    Wactawski-Wende, Jean
    Manson, JoAnn E.
    Qiao, Yongxia
    Liu, Simin
    Merriam, Philip A.
    Rahilly-Tierny, Catherine
    Thomas, Fridtjof
    Berger, Jeffrey S.
    Ockene, Judith K.
    Curb, J. David
    Ma, Yunsheng
    ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (02) : 144 - 152
  • [9] CONTINUOUS ESTROGEN-PROGESTIN THERAPY IN POSTMENOPAUSAL WOMEN
    SALPETER, S
    WESTERN JOURNAL OF MEDICINE, 1989, 151 (05): : 542 - 543
  • [10] After the women's health initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy
    Haskell, SG
    JOURNAL OF WOMENS HEALTH, 2004, 13 (04) : 438 - 442